BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6816017)

  • 41. [Plasma exchange therapy in hematology].
    Höcker P; Pittermann E
    Wien Klin Wochenschr; 1985 Feb; 97(3):115-22. PubMed ID: 4039090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
    Waldenström JG; Raiend U
    Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapy of Waldenström´s macroglobulinaemia in the year 2014].
    Adam Z; Krejčí M; Pour L; Ševčíková E
    Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The therapy of the paraproteinemias].
    Kanzow U
    Blut; 1969 May; 19(2):113-22. PubMed ID: 4977326
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hyperviscosity syndrome, macroglobulinemia].
    Hatta Y; Sawada U
    Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
    [No Abstract]   [Full Text] [Related]  

  • 47. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    Case DC; Lee DJ; Clarkson BD
    Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
    [No Abstract]   [Full Text] [Related]  

  • 48. [PARAPROTEINEMIAS].
    MARTI HR
    Schweiz Med Wochenschr; 1965 Mar; 95():381-7. PubMed ID: 14277003
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV; Gorodetskiĭ VM
    Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute renal failure in essential mixed cryoglobulinemia: precipitation and reversal by plasma exchange.
    Evans TW; Nicholls AJ; Shortland JR; Ward AM; Brown CB
    Clin Nephrol; 1984 May; 21(5):287-93. PubMed ID: 6733996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia.
    Berkman EM; Orlin JB
    Transfusion; 1980; 20(2):171-8. PubMed ID: 7368265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of serum immunoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange.
    Filomena CA; Filomena AP; Hudock J; Ballas SK
    Am J Clin Pathol; 1992 Aug; 98(2):243-8. PubMed ID: 1510038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of post-apheresis autoantibody rebound in cryoglobulinemia and cold agglutinin hemolytic anemia.
    L'Abbate A; Maggiore Q; Caccamo A; Bartolomeo F; Misefari V
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():51-6. PubMed ID: 6642738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Waldenström macroglobulinemia: a review of therapy.
    Gertz MA
    Am J Hematol; 2005 Jun; 79(2):147-57. PubMed ID: 15929102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis.
    Lévy V; Morel P; Porcher R; Chevret S; Wattel E; Leblond V
    Haematologica; 2005 Feb; 90(2):279-81. PubMed ID: 15710594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent Mixed Cryoglobulinemia (MCS): A Case Report and Literature Review.
    Bhattarai M; Woytowitz DV; Kaldash H; Bastacky S; Chen SS; Johnston JR; Bernardo JF
    R I Med J (2013); 2015 Oct; 98(10):33-7. PubMed ID: 26422544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myelopathy manifesting as macroglobulinemia].
    Woimant F; Schanen A; Bertail MA; Dupuy M; Lecoz P; Haguenau M; Pépin B
    Ann Med Interne (Paris); 1985; 136(2):121-4. PubMed ID: 3935023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapeutic plasmapheresis in essential monoclonal cryoglobulinemia].
    Golenkov AK; Zlatkina AR; Ivanov MI; Lipats AA; Podushko TA
    Sov Med; 1983; (1):96-7. PubMed ID: 6836402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.